American Medical Systems Holdings, Inc.
10700 Bren Road West
Minnetonka, Minnesota 55343
Re: Registration Statements on Form S-3 (Filing No. 333-135135) of American Medical Systems Holdings, Inc.
Ladies and Gentlemen:
We have acted as counsel to American Medical Systems Holdings, Inc., a Delaware corporation (the “Company”), in connection with the Company’s automatic shelf Registration Statement on Form S-3 (Registration No. 333-135135), which was filed with the Securities and Exchange Commission (the “Commission”) on June 19, 2006 (the “Registration Statement”) and which became effective upon filing under Rule 462(e) of the rules and regulations of the Commission under the Securities Act of 1933, as amended (the “Act”). The Registration Statement provides for the offering, issuance and sale, from time to time, of the securities described in the Registration Statement.
This opinion updates and supplements our opinion dated June 19, 2006, filed as an exhibit to the Registration Statement. At your request, this opinion is being furnished to you for filing on a Current Report on Form 8-K of the Company dated June 28, 2006 (the “June 28, 2006 Form 8-K”) and incorporation by reference as Exhibit 5.1 to the Registration Statement.
Pursuant to the terms of the Registration Statement, the Company is offering an aggregate principal amount of $373,750,000 of 31/4% Convertible Senior Subordinated Notes due 2036 (the “Notes”), including $48,750,000 of Notes that are subject to an over-allotment option granted to the underwriters. Said Notes are to be sold to the underwriters pursuant to that certain Purchase Agreement (the “Debt Purchase Agreement”), dated June 19, 2006, by and between the Company and the underwriter named therein, for sale to the public. The Notes will be issued pursuant to an Indenture (the “Indenture”), dated June 27, 2006 between the Company and U.S. Bank National Association, as Trustee (the “Trustee”), the form of which is being filed as Exhibit 4.1 to the Company’s June 28, 2006 Form 8-K.
As your counsel, we have examined the proceedings taken by you in connection with the authorization, issuance and sale of the Notes. We have examined such documents and considered such questions of law as we have deemed necessary or appropriate. We have also assumed the authenticity of all documents submitted to us as originals, the conformity with originals of all documents submitted to us as copies, and the genuineness of all signatures.
In particular, we have examined copies of the following: (i) the Certificate of Incorporation of the Company, as amended, (ii) the Bylaws of the Company, as amended, (iii) the Indenture, (iv) the form of Note filed with the Commission as Exhibit 4.2 to the June 28, 2006 Form 8-K, (v) the prospectus contained in the Registration Statement at the time it became effective (the “Base Prospectus”), (vi) the preliminary prospectus supplement, dated June 19, 2006, relating to the offering of the Notes, in the form filed with the Commission under Rule 430B and 424(b) promulgated under the Act (the “Preliminary Prospectus”), and (vii) the final prospectus supplement, dated June 21, 2006, relating to the offering of the Notes, in the form filed with the Commission under Rule 430B and Rule 424(b) promulgated under the Act (the “Final Prospectus”).
We have also assumed the legal capacity of all natural persons and that, with respect to all parties to agreements or instruments relevant hereto other than the Company, such parties had the requisite power and authority to execute, deliver and perform such agreements or instruments, that such agreements or instruments have been duly authorized by all requisite action, executed and delivered by such parties, and that such agreements or instruments are the valid, binding and enforceable obligations of such parties.